Health Technology · Pharmaceuticals: Major · NSE: VILINBIO · data 2026-10-09

Vilin Bio Med Ltd.

Health check: Strong (7.5/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹52

Market cap

₹75 cr

P/E

40.8

P/B

2.8

ROE

7.5%

ROCE

11.3%

Debt / equity

0.01

Dividend yield

0.00%

1-year return

114.0%

52-week high

₹60.95

52-week low

₹18.95

Operating margin

6.9%

Growth

Revenue (last 12 months)	₹42 cr
Net profit (last 12 months)	₹2 cr
Sales growth, 3 years (yearly)	50.8%
Profit growth, 3 years (yearly)	15.7%

Similar companies

Vaishali Pharma Ltd. (VAISHALI) · Sunil Healthcare Ltd. (SUNLOC) · Zenith Drugs Ltd. (ZENITHDRUG) · Onyx Biotec Ltd. (ONYX) · Vivimed Labs Limited (VIVIMEDLAB)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open VILINBIO in NSE Scanner →